出院时继续使用新发和慢性潜在不适当药物与不良事件风险增加相关
该前瞻性队列研究纳入加拿大麦吉尔大学健康中心网络内三级医院的内科、心脏科和胸外科65岁及以上住院患者,评估出院时潜在不适当药物(PIM)数量及其与出院后30天不良事件的关系。结果显示66%患者出院时至少被处方一种PIM,每增加一种新PIM和持续社区PIM分别与不良药物事件(ADE)风险增加21%和10%相关。
要点
- 66%的老年住院患者出院时至少被处方一种PIM。
- 每增加一种新PIM,ADE风险增加21%(OR=1.21)。
- 每增加一种持续社区PIM,ADE风险增加10%(OR=1.10)。
核心结论
- 出院时处方PIM常见,且新发和持续PIM数量增加与出院后30天ADE及全因不良事件风险升高相关。
研究设计与样本
- 前瞻性队列研究,纳入加拿大蒙特利尔麦吉尔大学健康中心网络内三级医院内科、心脏科和胸外科65岁及以上住院患者,2014年10月至2016年11月入院,共2402例。
主要发现
- 2402例患者中,1381例(57%)为男性,中位年龄76岁(IQR=70-82岁),出院时处方药物中位数8种(IQR=2-8)。
- 1576例(66%)出院时至少被处方一种PIM,其中1176例(49%)继续使用入院前PIM,755例(31%)至少被处方一种新PIM。
- 出院后30天内,218例(9%)发生ADE,862例(36%)就诊急诊、再住院或死亡。
- 调整后,每增加一种新PIM与ADE风险增加21%相关(OR=1.21;95%CI=1.01-1.45),每增加一种持续社区PIM与ADE风险增加10%相关(OR=1.10;95%CI=1.01-1.21)。
- 每增加一种新PIM和持续社区PIM分别与急诊就诊、再住院和死亡风险增加13%(HR=1.13;95%CI=1.03-1.26)和5%(HR=1.05;95%CI=1.00-1.10)相关。
关键数值与推荐
- PIM识别使用AGS Beers标准、STOPP和Choosing Wisely声明。
临床怎么用
- 住院期间及出院时应系统审查老年患者用药,关注新发和持续PIM,以减少出院后不良事件。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Admission to hospital provides the opportunity to review patient medications; however, the extent to which the safety of drug regimens changes after hospitalization is unclear. OBJECTIVE: To estimate the number of potentially inappropriate medications (PIMs) prescribed to patients at hospital discharge and their association with the risk of adverse events 30 days after discharge. DESIGN: Prospective cohort study. SETTING: Tertiary care hospitals within the McGill University Health Centre Network in Montreal, Quebec, Canada. PARTICIPANTS: Patients from internal medicine, cardiac, and thoracic surgery, aged 65 years and older, admitted between October 2014 and November 2016. MEASURES: Abstracted chart data were linked to provincial health databases. PIMs were identified using AGS (American Geriatrics Society) Beers Criteria®, STOPP, and Choosing Wisely statements. Multivariable logistic regression and Cox models were used to assess the association between PIMs and adverse events. RESULTS: Of 2,402 included patients, 1,381 (57%) were male; median age was 76 years (interquartile range [IQR] = 70-82 years); and eight discharge medications were prescribed (IQR = 2-8). A total of 1,576 (66%) patients were prescribed at least one PIM at discharge; 1,176 (49%) continued a PIM from prior to admission, and 755 (31%) were prescribed at least one new PIM. In the 30 days after discharge, 218 (9%) experienced an adverse drug event (ADE) and 862 (36%) visited the emergency department (ED), were rehospitalized, or died. After adjustment, each additional new PIM and continued community PIM were respectively associated with a 21% (odds ratio [OR] = 1.21; 95% confidence interval [CI] = 1.01-1.45) and a 10% (OR = 1.10; 95% CI = 1.01-1.21) increased odds of ADEs. They were also respectively associated with a 13% (hazard ratio [HR] = 1.13; 95% CI = 1.03-1.26) and a 5% (HR = 1.05; 95% CI = 1.00-1.10) increased risk of ED visits, rehospitalization, and death. CONCLUSIONS: Two in three hospitalized patients were prescribed a PIM at discharge, and increasing numbers of PIMs were associated with an increased risk of ADEs and all-cause adverse events. Improving hospital prescribing practices may reduce the frequency of PIMs and associated adverse events. J Am Geriatr Soc 68:1184-1192, 2020.
引用
- Weir DL, Lee TC, McDonald EG, et al. Both New and Chronic Potentially Inappropriate Medications Continued at Hospital Discharge Are Associated With Increased Risk of Adverse Events. J Am Geriatr Soc. 2020. PMID: 32232988. doi:10.1111/jgs.16413
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。